FatPipe (FATN) shares surged over 200% in their trading debut on Nasdaq Tuesday after the company priced its initial public offering of 695,656 shares at $5.75 apiece to raise about $4 million.
60 Degrees Pharmaceuticals (SXTP) said it signed a patent license deal with Yale School of Medicine and Yale School of Public Health to jointly develop and commercialize Tafenoquine for the treatment and prevention of tick-borne disease babesiosis.
Shares surged 64%, with intraday trading volume catapulted to over 73.8 million from a daily average of about 419,000.
Price: 18.25, Change: +12.50, Percent Change: +217.30
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。